Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study addresses a "lifespan approach to healthy development and aging" with direct
relevance to humans by testing the anti-aging effects of acarbose in humans. It is a pilot
study to: i) better estimate power for a larger trial, ii) establish the safety and potential
beneficial effects of acarbose in non-diabetic elderly humans, and iii) determine whether the
effects of acarbose on the microbiome likely play a role in its enhancement of longevity
and/or healthy aging. These are essential initial steps for translating acarbose into an
anti-aging human therapy.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio